Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JCDr. Judith Currier

    Dr. Judith Currier

    Infectious Disease · HIV & AIDS Medicine
    University of California, Los Angeles
    judithc

    Research

    Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study

    2026

    Via medRxiv

    Research

    Association of long COVID with health-related quality-of-life outcomes

    2026

    Via Sci Rep

    Research

    Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution

    2026

    Via Microbiol Spectr

    Research

    Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

    2026

    Via The Lancet HIV

    Research

    Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19

    2026

    Via Pathogens & Immunity

    Research

    High usage of telephone telemedicine among people living with HIV at two federally qualified health centers in Los Angeles

    2026

    Via BMC Health Services Research

    Research

    Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

    2025

    Via Open Forum Infect Dis

    Research

    Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial

    2025

    Via JAMA Cardiology

    Research

    Statin Effects on the Incidence of Major Non-Cardiovascular Disease Events Among a Global Cohort of People With HIV: A Randomised Controlled Trial

    2025

    Via The Lancet. HIV

    Research

    Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort

    2025

    Via Open Forum Infectious Diseases

    Research

    Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy

    2025

    Via JACC. Advances

    Research

    Viral and Symptom Rebound Following Anti-SARS-CoV-2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

    2025

    Via The Journal of Infectious Diseases

    Research

    Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

    2025

    Via iScience

    Research

    Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

    2025

    Via Contemporary Clinical Trials

    Research

    Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of initial treatment for people living with HIV

    2025

    Via Clinical Trials